What Boston Scientific’s evolving supply chain strategy means for partners, productivity and M&A

What Boston Scientific’s evolving supply chain strategy means for partners, productivity and M&A
DeviceTalks Podcast Network
What Boston Scientific’s evolving supply chain strategy means for partners, productivity and M&A

Sep 16 2022 | 01:07:46

/
Episode September 16, 2022 01:07:46

Hosted By

Kayleen Brown Tom Salemi

Show Notes

The medical device industry obviously isn’t immune to the challenges posed by a shaky supply chain. But OEM leaders like Boston Scientific need to work doubly hard to ensure they have the supplies needed to provide devices for patient care. In this episode, we’ll talk with Brad Sorenson, executive vice president, Global Operations, and Paudie O’Connor, senior vice president of supply chain, to learn how Boston Scientific has managed the crisis. Topics we cover include supplier relationships, the value (and risk) of redundancies, how to reducing shipping costs and other critical topics. Supply chain executives at OEMs and smaller vendors will value from the conversation. Thanks to Paxxus for sponsoring this episode. Chris Newmarker also returns to share his Newmarkers Newsmakers – Edwards Lifesciences, Verily, Johnson & Johnson, Smith+ Nephew, and MassDevice’s Big 100! Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe on any major podcast player.

Other Episodes